Cashu FinanceCashu Finance
  • Terminal
  • Pulse
  • Spotlight
  • News
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Consumer Defensive
  3. NYSE
  4. KVUE

Market Cap: $37.09B

KI

Kenvue Inc.

KVUE
NYSE (New York Stock Exchange)USD
Invest in KVUE
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksScreenersAboutAuthorsAdvertisersBrokersConferencesContact

Legal

Terms of ServicePrivacy PolicyEditorial PolicyCorrections Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

$19.31
-$0.25(-1.28%)
At close: Nov 18, 20:34 EST

More on Kenvue Inc.

  • News & announcements
  • Financials

Kenvue Inc. at a Glance

  • Profitable, with a net margin of 10.9% over the last 12 months.

Open

$19.73

Prev. Close

$19.56

High

$19.74

Low

$19.27

Key Statistics

52-Week Range80% of range
Low $15.94High $20.13
Market Cap
$37.09B
P/E Ratio
21.94x
EPS (TTM)
$0.88
Revenue (TTM)
$15.53B
Dividend Yield
5.40%
Price / Book
3.65x
Beta
0.45
Avg. Volume
21.8M

Company Profile

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

CEOKirk L. Perry
SectorConsumer Defensive
IndustryHousehold & Personal Products
Employees21.9K
IPO DateMay 4, 2023
ExchangeNYSE
Exchange NameNew York Stock Exchange
CurrencyUSD
Headquarters & Contact
Address1 Kenvue Way
City / State / ZIPSummit, NJ, 07901
CountryUnited States
Phone

KVUE Stock FAQ

What does Kenvue Inc. do?

Kenvue Inc. functions as a global leader in the consumer health sector.

Where is Kenvue Inc. stock listed?

Kenvue Inc. trades on the New York Stock Exchange under the ticker KVUE, priced in USD.

What is Kenvue Inc.'s market cap?

Kenvue Inc. has a market capitalisation of $37.09B, based on its latest share price.

What is the P/E ratio of KVUE?

KVUE trades at 21.94 times its trailing 12-month earnings.

What is KVUE's 52-week high and low?

Over the past 52 weeks KVUE has traded between $15.94 and $20.13.

Does Kenvue Inc. pay a dividend?

Yes. Kenvue Inc.'s dividend yields 5.40% at the current share price, paying out 94% of its earnings.

Is Kenvue Inc. profitable?

Profitable, with a net margin of 10.9% over the last 12 months.

What do analysts think of KVUE stock?

The analyst consensus rating for KVUE is Hold. Analysts' average 12-month price target of $18.67 implies 3% downside.

Who is the CEO of Kenvue Inc.?

Kirk L. Perry is the CEO of Kenvue Inc., which is headquartered in Summit.

Shares trade 29% below a discounted cash flow (DCF) estimate of $27.31.
  • Moderate debt: borrowings are 0.82x shareholders' equity.
  • Short-term obligations exceed short-term assets (current ratio 0.96).
  • Analysts' average 12-month price target of $18.67 implies 3% downside.
  • Pays a dividend yielding 5.40%, paying out 94% of earnings.
  • Generated automatically from reported financial data. General information only, not financial advice.

    Fundamentals Scorecard

    Each pillar is scored out of 5 from the latest reported data.

    • Valuation

      Fair · 3.0/5

      Price vs earnings, book value and discounted cash flow.

    • Profitability

      Strong · 4.0/5

      Return on equity and return on assets.

    • Financial Health

      Fair · 2.5/5

      Debt levels and Altman Z-Score bankruptcy risk.

    • Fundamental Trend

      Fair · 3.3/5

      Piotroski F-Score: 9 checks on profit, leverage and efficiency.

    See the full financial breakdown →

    Recently from Cashu

    Kenvue's Transformation Post-Acquisition

    Kenvue's Transformation Post-Acquisition

    Kenvue's Transformation Post-Acquisition Kenvue Inc. ( KVUE ) has recently entered a new chapter following its acquisition by Kimberly-Clark, a strategic move that marks a significant shift in the lan…

    Cashu Finance·16 days ago

    Kenvue Showcases Consumer Health Commitment at 2025 CAGNY Conference

    Kenvue’s Commitment to Consumer Health Takes Center Stage at Upcoming CAGNY Conference Kenvue Inc., recognized as the world's largest pure-play consumer health company by revenue, prepares to engage w…

    Cashu Finance·almost 2 years ago

    Kenvue's Strategic Response to Shareholder Engagement and Market Challenges

    Kenvue's Strategic Response to Shareholder Engagement Kenvue Inc., the largest pure-play consumer health company globally by revenue, takes decisive steps in response to shareholder engagement, partic…

    Cashu Finance·almost 2 years ago

    Kenvue Prepares for Q4 2024 Financial Results Announcement on February 6, 2025

    Kenvue Sets the Stage for Q4 2024 Financial Results Announcement Kenvue Inc., recognized as the world's largest pure-play consumer health company by revenue, prepares to unveil its fourth quarter and…

    Cashu Finance·almost 2 years ago
    908 874 1200
    Websitehttps://www.kenvue.com